Protego Biopharma, Inc.
Biotechnology company · San Diego, California, United States
Protego Biopharma, Inc. is a biotechnology company headquartered in San Diego, California, United States. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $3.7 million in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $33 million sold in a notice filed in 2025.
Protego Biopharma at a glance
What does Protego Biopharma do?
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $3.7 million in total (2018 to 2021). NIH funding came from the National Institute of Neurological Disorders and Stroke, National Center for Advancing Translational Sciences.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $32.9 million sold (2025).
Frequently asked questions about Protego Biopharma
Where is Protego Biopharma headquartered?
Protego Biopharma, Inc. is headquartered in San Diego, California, United States.
What does Protego Biopharma do?
Protego Biopharma, Inc. is a biotechnology company.
Similar companies
- Biolinq IncSan Diego, California, United States
- BioAtla, Inc.San Diego, California, United States
- Neurocrine Biosciences IncSan Diego, California, United States
- ImmunityBio, Inc.San Diego, California, United States
- Sorrento Therapeutics, Inc.San Diego, California, United States
- Tempo Therapeutics, Inc.San Diego, California, United States
- Fate Therapeutics IncSan Diego, California, United States
- ImageneBio, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.